Meeting of the Advisory Committee on Infant and Maternal Mortality (Formerly the Advisory Committee on Infant Mortality), 8436 [2023-02791]
Download as PDF
<![CDATA[
8436
Federal Register / Vol. 88, No. 27 / Thursday, February 9, 2023 / Notices
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period. To
meet its burden, the petition must
comply with all the requirements of
§ 60.30, including but not limited to:
must be timely (see DATES), must be
filed in accordance with § 10.20, must
contain sufficient facts to merit an FDA
investigation, and must certify that a
true and complete copy of the petition
has been served upon the patent
applicant. (See H. Rept. 857, part 1, 98th
Cong., 2d sess., pp. 41–42, 1984.)
Petitions should be in the format
specified in 21 CFR 10.30.
Submit petitions electronically to
https://www.regulations.gov at Docket
No. FDA–2013–S–0610. Submit written
petitions (two copies are required) to the
Dockets Management Staff (HFA–305),
Food and Drug Administration, 5630
Fishers Lane, Rm. 1061, Rockville, MD
20852.
Dated: February 6, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–02743 Filed 2–8–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Infant and Maternal Mortality (Formerly
the Advisory Committee on Infant
Mortality)
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Infant and Maternal
Mortality (ACIMM or Committee) has
scheduled a public meeting. Information
about ACIMM and the agenda for this
meeting can be found on the ACIMM
website at https://www.hrsa.gov/
advisory-committees/infant-mortality/
index.html.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
March 20, 2023, 11:30 a.m. to
4:30 p.m. Eastern Time and March 21,
2023, 11:30 a.m. to 3:00 p.m. Eastern
Time.
DATES:
This meeting will be held
by webinar. The webinar link and login information will be available at the
ACIMM website before the meeting:
ADDRESSES:
VerDate Sep<11>2014
16:28 Feb 08, 2023
Jkt 259001
https://www.hrsa.gov/advisorycommittees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health
Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, Maryland
20857; 301–443–0543; or SACIM@
hrsa.gov.
SUPPLEMENTARY INFORMATION:
ACIMM is authorized by section 222
of the Public Health Service Act (42
U.S.C. 217a), as amended. The
Committee is governed by provisions of
Public Law 92–463, as amended by
Public Law 117–286 (5 U.S.C. 10),
which sets forth standards for the
formation and use of Advisory
Committees.
ACIMM advises the Secretary of
Health and Human Services (Secretary)
on department activities, partnerships,
policies, and programs directed at
reducing infant mortality, maternal
mortality and severe maternal
morbidity, and improving the health
status of infants and women before,
during, and after pregnancy. The
Committee provides advice on how to
coordinate federal, state, local, tribal,
and territorial governmental efforts
designed to improve infant mortality,
related adverse birth outcomes,
maternal health, as well as influence
similar efforts in the private and
voluntary sectors. The Committee
provides guidance and
recommendations on the policies,
programs, and resources required to
address the disparities and inequities in
infant mortality, related adverse birth
outcomes and maternal health
outcomes, including maternal mortality
and severe maternal morbidity. With its
focus on underlying causes of the
disparities and inequities seen in birth
outcomes for women and infants, the
Committee advises the Secretary on the
health, social, economic, and
environmental factors contributing to
the inequities and proposes structural,
policy, and/or systems level changes.
The agenda for the March 20–21,
2023, meeting is being finalized and
may include the following topics: an
update on the recommendations
submitted to the Secretary on improving
birth outcomes among American Indian
and Alaska Native mothers and infants;
a discussion to determine new and
continuing priority areas for the
Committee; federal updates; and
Committee operations. Agenda items are
subject to change as priorities dictate.
Refer to the ACIMM website listed
above for any updated information
concerning the meeting.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Members of the public will have the
opportunity to provide comments.
Requests to submit a written statement
or make oral comments to ACIMM
should be sent to Vanessa Lee, using the
email address above at least 3 business
days prior to the meeting. Public
participants may submit written
statements in advance of the scheduled
meeting by emailing SACIM@hrsa.gov.
Oral comments will be honored in the
order they are requested and may be
limited as time allows.
Individuals who plan to attend and
need special assistance or a reasonable
accommodation should notify Vanessa
Lee at the contact information listed
above at least 10 business days prior to
the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–02791 Filed 2–8–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of the President’s
Advisory Commission on Asian
Americans, Native Hawaiians, and
Pacific Islanders Meeting
Department of Health and
Human Services, Office of the Secretary,
Office for Civil Rights, White House
Initiative on Asian Americans, Native
Hawaiians, and Pacific Islanders.
ACTION: Notice of meeting.
AGENCY:
As required by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that the President’s Advisory
Commission on Asian Americans,
Native Hawaiians, and Pacific Islanders
will hold a meeting on March 14, 2023.
DATES: The Commission will meet on
March 14, 2023, from approximately
9:00 a.m. Eastern Time (ET) to
approximately 5:30 p.m. ET. The
confirmed time and agenda will be
posted on the website for the President’s
Advisory Commission on Asian
Americans, Native Hawaiians, and
Pacific Islanders: https://www.hhs.gov/
about/whiaanhpi/commission/
meetings/ when this
information becomes available.
ADDRESSES: The meeting will be live
streamed. Registration is required
through the following link: https://
www.eventbrite.com/e/meeting-of-thepresidents-advisory-commission-on-aaand-nhpis-registration-517786452217.
FOR FURTHER INFORMATION CONTACT:
Caroline Goon, Designated Federal
SUMMARY:
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 88, Number 27 (Thursday, February 9, 2023)]
[Notices]
[Page 8436]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02791]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant and Maternal
Mortality (Formerly the Advisory Committee on Infant Mortality)
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Infant and Maternal
Mortality (ACIMM or Committee) has scheduled a public meeting.
Information about ACIMM and the agenda for this meeting can be found on
the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/.
DATES: March 20, 2023, 11:30 a.m. to 4:30 p.m. Eastern Time and March
21, 2023, 11:30 a.m. to 3:00 p.m. Eastern Time.
ADDRESSES: This meeting will be held by webinar. The webinar link and
log-in information will be available at the ACIMM website before the
meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, Maryland 20857; 301-443-0543; or [email protected].
SUPPLEMENTARY INFORMATION:
ACIMM is authorized by section 222 of the Public Health Service Act
(42 U.S.C. 217a), as amended. The Committee is governed by provisions
of Public Law 92-463, as amended by Public Law 117-286 (5 U.S.C. 10),
which sets forth standards for the formation and use of Advisory
Committees.
ACIMM advises the Secretary of Health and Human Services
(Secretary) on department activities, partnerships, policies, and
programs directed at reducing infant mortality, maternal mortality and
severe maternal morbidity, and improving the health status of infants
and women before, during, and after pregnancy. The Committee provides
advice on how to coordinate federal, state, local, tribal, and
territorial governmental efforts designed to improve infant mortality,
related adverse birth outcomes, maternal health, as well as influence
similar efforts in the private and voluntary sectors. The Committee
provides guidance and recommendations on the policies, programs, and
resources required to address the disparities and inequities in infant
mortality, related adverse birth outcomes and maternal health outcomes,
including maternal mortality and severe maternal morbidity. With its
focus on underlying causes of the disparities and inequities seen in
birth outcomes for women and infants, the Committee advises the
Secretary on the health, social, economic, and environmental factors
contributing to the inequities and proposes structural, policy, and/or
systems level changes.
The agenda for the March 20-21, 2023, meeting is being finalized
and may include the following topics: an update on the recommendations
submitted to the Secretary on improving birth outcomes among American
Indian and Alaska Native mothers and infants; a discussion to determine
new and continuing priority areas for the Committee; federal updates;
and Committee operations. Agenda items are subject to change as
priorities dictate. Refer to the ACIMM website listed above for any
updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Requests to submit a written statement or make oral comments
to ACIMM should be sent to Vanessa Lee, using the email address above
at least 3 business days prior to the meeting. Public participants may
submit written statements in advance of the scheduled meeting by
emailing [email protected]. Oral comments will be honored in the order
they are requested and may be limited as time allows.
Individuals who plan to attend and need special assistance or a
reasonable accommodation should notify Vanessa Lee at the contact
information listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-02791 Filed 2-8-23; 8:45 am]
BILLING CODE 4165-15-P
